These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
81 related items for PubMed ID: 7950982
1. Evidence for chemical differentiation of delta opioid receptor subtypes by the sulfhydryl reagent N-ethylmaleimide. Tam L, Rafferty MF. Receptor; 1994; 4(2):81-91. PubMed ID: 7950982 [Abstract] [Full Text] [Related]
2. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens. Wild KD, Carlisi VJ, Mosberg HI, Bowen WD, Portoghese PS, Sultana M, Takemori AE, Hruby VJ, Porreca F. J Pharmacol Exp Ther; 1993 Feb; 264(2):831-8. PubMed ID: 8382281 [Abstract] [Full Text] [Related]
3. Differential antagonism by naltrindole-5'-isothiocyanate on [3H]DSLET and [3H]DPDPE binding to striatal slices of mice. Chakrabarti S, Sultana M, Portoghese PS, Takemori AE. Life Sci; 1993 Feb; 53(23):1761-5. PubMed ID: 8246672 [Abstract] [Full Text] [Related]
4. Alkylation of opioid receptors by 5'-naltrindole-isothiocyanate injected into the nucleus accumbens of rats: receptor selectivity and anatomical diffusion. Martin TJ, McIntosh S, Smith JE. Synapse; 2006 Oct; 60(5):384-91. PubMed ID: 16847946 [Abstract] [Full Text] [Related]
5. Postnatal development of delta-opioid receptor subtypes in mice. Negri L, Severini C, Lattanzi R, Potenza RL, Melchiorri P. Br J Pharmacol; 1997 Mar; 120(6):989-94. PubMed ID: 9134207 [Abstract] [Full Text] [Related]
6. Affinity labeling of delta opioid receptors by an enkephalin-derivative alkylating agent, DSLET-Mal. Szatmári I, Orosz G, Medzihradszky K, Borsodi A. Biochem Biophys Res Commun; 1999 Nov 19; 265(2):513-9. PubMed ID: 10558900 [Abstract] [Full Text] [Related]
7. Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity. Fang L, Knapp RJ, Horvath R, Matsunaga TO, Haaseth RC, Hruby VJ, Porreca F, Yamamura HI. J Pharmacol Exp Ther; 1994 Feb 19; 268(2):836-46. PubMed ID: 8113996 [Abstract] [Full Text] [Related]
8. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors. Zhao GM, Qian X, Schiller PW, Szeto HH. J Pharmacol Exp Ther; 2003 Dec 19; 307(3):947-54. PubMed ID: 14534366 [Abstract] [Full Text] [Related]
9. delta-Opioid receptor binding in mouse brain: evidence for heterogeneous binding sites. Sofuoglu M, Portoghese PS, Takemori AE. Eur J Pharmacol; 1992 Jun 05; 216(2):273-7. PubMed ID: 1327813 [Abstract] [Full Text] [Related]
10. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands. Calderon SN, Rice KC, Rothman RB, Porreca F, Flippen-Anderson JL, Kayakiri H, Xu H, Becketts K, Smith LE, Bilsky EJ, Davis P, Horvath R. J Med Chem; 1997 Feb 28; 40(5):695-704. PubMed ID: 9057856 [Abstract] [Full Text] [Related]
11. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin. Stewart PE, Hammond DL. J Pharmacol Exp Ther; 1993 Aug 28; 266(2):820-8. PubMed ID: 8394918 [Abstract] [Full Text] [Related]
12. [3H]naltrindole: a potent and selective ligand for labeling delta-opioid receptors. Contreras PC, Tam L, Drower E, Rafferty MF. Brain Res; 1993 Feb 26; 604(1-2):160-4. PubMed ID: 8384509 [Abstract] [Full Text] [Related]
13. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells. Prather PL, Tsai AW, Law PY. J Pharmacol Exp Ther; 1994 Jul 26; 270(1):177-84. PubMed ID: 8035314 [Abstract] [Full Text] [Related]
14. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans. Ananthan S, Kezar HS, Carter RL, Saini SK, Rice KC, Wells JL, Davis P, Xu H, Dersch CM, Bilsky EJ, Porreca F, Rothman RB. J Med Chem; 1999 Sep 09; 42(18):3527-38. PubMed ID: 10479286 [Abstract] [Full Text] [Related]
15. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles. Ioja E, Tourwé D, Kertész I, Tóth G, Borsodi A, Benyhe S. Brain Res Bull; 2007 Sep 14; 74(1-3):119-29. PubMed ID: 17683797 [Abstract] [Full Text] [Related]
16. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor. Clark MJ, Emmerson PJ, Mansour A, Akil H, Woods JH, Portoghese PS, Remmers AE, Medzihradsky F. J Pharmacol Exp Ther; 1997 Nov 14; 283(2):501-10. PubMed ID: 9353363 [Abstract] [Full Text] [Related]
17. Participation of delta opioid receptor subtypes in the stimulation of adenylyl cyclase activity in rat olfactory bulb. Olianas MC, Onali P. J Pharmacol Exp Ther; 1995 Dec 14; 275(3):1560-7. PubMed ID: 8531129 [Abstract] [Full Text] [Related]
18. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system. Tao R, Auerbach SB. J Pharmacol Exp Ther; 2002 Nov 14; 303(2):549-56. PubMed ID: 12388635 [Abstract] [Full Text] [Related]
19. The effect of naltrindole on spinal and supraspinal delta opioid receptors and analgesia. Shah S, Davis T, Yoburn BC. Life Sci; 1994 Nov 14; 55(19):1451-8. PubMed ID: 7968211 [Abstract] [Full Text] [Related]
20. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites. Nishimura SL, Recht LD, Pasternak GW. Mol Pharmacol; 1984 Jan 14; 25(1):29-37. PubMed ID: 6323950 [Abstract] [Full Text] [Related] Page: [Next] [New Search]